121 related articles for article (PubMed ID: 36605447)
1. Risk factors to identify the indication for regional nodal irradiation in T1-2N1M0 breast cancer: A joint analysis of 4,243 real-world cases from two institutions.
Sun GY; Wen G; Zhang YJ; Tang Y; Jing H; Fang H; Wang JY; Zhang JH; Zhao XR; Chen SY; Song YW; Jin J; Liu YP; Tang Y; Qi SN; Li N; Chen B; Lu NN; Li YX; Wang SL
Front Oncol; 2022; 12():955381. PubMed ID: 36605447
[TBL] [Abstract][Full Text] [Related]
2. Radiotherapy plays an important role in improving the survival outcome in patients with T1-2N1M0 breast cancer - a joint analysis of 4262 real world cases from two institutions.
Sun GY; Wen G; Zhang YJ; Tang Y; Jing H; Wang JY; Zhang JH; Yang Y; Zhao XR; Chen SY; Jin J; Song YW; Liu YP; Fang H; Ren H; Tang Y; Qi SN; Li N; Chen B; Lu NN; Wang SL; Li YX
BMC Cancer; 2020 Nov; 20(1):1155. PubMed ID: 33243177
[TBL] [Abstract][Full Text] [Related]
3. Benefit of postoperative regional nodal irradiation in patients receiving preoperative systemic therapy with docetaxel/carboplatin/trastuzumab/pertuzumab for HER2-positive breast cancer.
Kim N; Kim JY; Park W; Cho WK; Kim TG; Im YH; Ahn JS; Lee JE; Nam SJ; Kim SW; Yu J; Chae BJ; Lee SK; Ryu JM; Park YH; Kim H
Breast; 2023 Dec; 72():103594. PubMed ID: 37924622
[TBL] [Abstract][Full Text] [Related]
4. Regional nodal irradiation in pT1-2N1 breast cancer patients treated with breast-conserving surgery and whole breast irradiation.
Park SH; Kim JC
Radiat Oncol J; 2020 Mar; 38(1):44-51. PubMed ID: 32229808
[TBL] [Abstract][Full Text] [Related]
5. [Risk-adapted postmastectomy radiotherapy based on local-regional recurrence for T1-2N1M0 breast Cancer].
Li M; Wang SL; Fang H; Tang Y; Chen B; Qi SN; Song YW; Liu YP; Lu NN; Li N; Tang Y; Ren H; Jin J; Li YX
Zhonghua Zhong Liu Za Zhi; 2017 Nov; 39(11):841-849. PubMed ID: 29151291
[No Abstract] [Full Text] [Related]
6. Long-Term Impact of Regional Nodal Irradiation in Patients With Node-Positive Breast Cancer Treated With Neoadjuvant Systemic Therapy.
Stecklein SR; Park M; Liu DD; Valle Goffin JJ; Caudle AS; Mittendorf EA; Barcenas CH; Mougalian S; Woodward WA; Valero V; Sahin AA; Yang WT; Shaitelman SF
Int J Radiat Oncol Biol Phys; 2018 Nov; 102(3):568-577. PubMed ID: 29928946
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for regional nodal failure after breast-conserving therapy: regional nodal irradiation reduces rate of axillary failure in patients with four or more positive lymph nodes.
Grills IS; Kestin LL; Goldstein N; Mitchell C; Martinez A; Ingold J; Vicini FA
Int J Radiat Oncol Biol Phys; 2003 Jul; 56(3):658-70. PubMed ID: 12788171
[TBL] [Abstract][Full Text] [Related]
8. De-escalated radiotherapy for HER2-overexpressing breast cancer patients with 1-3 positive lymph nodes undergoing anti-HER2 targeted therapy.
Liu J; Huang S; Bi Z; Zhang X; He Z; Lan X; Tan Y; Lin X; Zhou W; Huang X
Front Oncol; 2023; 13():1280900. PubMed ID: 38023183
[TBL] [Abstract][Full Text] [Related]
9. The Role of the Neo-Bioscore Staging System in Guiding the Optimal Strategies for Regional Nodal Irradiation Following Neoadjuvant Treatment in Breast Cancer Patients with cN1 and ypN0-1.
Cao L; Xu C; Kirova YM; Cai G; Cai R; Wang SB; Shen KW; Ou D; Chen JY
Ann Surg Oncol; 2019 Feb; 26(2):343-355. PubMed ID: 30519764
[TBL] [Abstract][Full Text] [Related]
10. Regional Nodal Irradiation After Breast Conserving Surgery for Early HER2-Positive Breast Cancer: Results of a Subanalysis From the ALTTO Trial.
Gingras I; Holmes E; De Azambuja E; Nguyen DH; Izquierdo M; Anne Zujewski J; Inbar M; Naume B; Tomasello G; Gralow JR; Wolff AC; Harris L; Gnant M; Moreno-Aspitia A; Piccart MJ; Azim HA
J Natl Cancer Inst; 2017 Aug; 109(8):. PubMed ID: 28376188
[TBL] [Abstract][Full Text] [Related]
11. Use of regional nodal irradiation and its association with survival for women with high-risk, early stage breast cancer: A National Cancer Database analysis.
Moreno AC; Lin YH; Bedrosian I; Shen Y; Stauder MC; Smith BD; Buchholz TA; Babiera GV; Woodward WA; Shaitelman SF
Adv Radiat Oncol; 2017; 2(3):291-300. PubMed ID: 29114595
[TBL] [Abstract][Full Text] [Related]
12. Internal mammary node irradiation improves 8-year survival in breast cancer patients: results from a retrospective cohort study in real-world setting.
Wang X; Luo J; Jin K; Chen X; Zhang L; Meng J; Zhang X; Zhang Z; Shao Z; Bazan JG; Guo X; Yang Z; Yu X
Breast Cancer; 2020 Mar; 27(2):252-260. PubMed ID: 31696449
[TBL] [Abstract][Full Text] [Related]
13. Evaluating Regional Nodal Irradiation Allocation and Association with Oncologic Outcomes in NSABP B-18, B-27, B-40, and B-41.
Mailhot Vega RB; Wang S; Brooks ED; Oladeru OT; Lockney NA; Spiguel LE; MacDonald SM; Mamounas EP; Mendenhall NP; Okunieff PG; Lee JH; Bradley JA
Int J Radiat Oncol Biol Phys; 2022 Jul; 113(3):542-551. PubMed ID: 35418342
[TBL] [Abstract][Full Text] [Related]
14. Association Between Regional Nodal Irradiation and Breast Cancer Recurrence-Free Interval for Patients With Low-Risk, Node-Positive Breast Cancer.
Sit D; Lalani N; Chan E; Tran E; Speers C; Gondara L; Chia S; Gelmon K; Lohrisch C; Nichol A
Int J Radiat Oncol Biol Phys; 2022 Mar; 112(4):861-869. PubMed ID: 34762971
[TBL] [Abstract][Full Text] [Related]
15. Eight-year follow up result of the OTOASOR trial: The Optimal Treatment Of the Axilla - Surgery Or Radiotherapy after positive sentinel lymph node biopsy in early-stage breast cancer: A randomized, single centre, phase III, non-inferiority trial.
Sávolt Á; Péley G; Polgár C; Udvarhelyi N; Rubovszky G; Kovács E; Győrffy B; Kásler M; Mátrai Z
Eur J Surg Oncol; 2017 Apr; 43(4):672-679. PubMed ID: 28139362
[TBL] [Abstract][Full Text] [Related]
16. [The role of postmastectomy radiotherapy in clinical T1-3N1M0 breast cancer patients with pathological negative lymph nodes after neoadjuvant chemotherapy and mastectomy].
Rong QL; Wang SL; Tang Y; Jin J; Song YW; Wang WH; Liu YP; Fang H; Ren H; Liu XF; Yu ZH; Li YX
Zhonghua Zhong Liu Za Zhi; 2017 Jun; 39(6):445-452. PubMed ID: 28635235
[No Abstract] [Full Text] [Related]
17. [The 8th edition of the American Joint Committee on Cancer staging system provide improved prognostic accuracy in T1-2N1M0 postmastectomy breast cancer patients].
Sun GY; Wang SL; Tang Y; Yang Y; Fang H; Wang JY; Jing H; Zhang JH; Jin J; Song YW; Liu YP; Chen B; Qi SN; Li N; Tang Y; Lu NN; Wang WH; Chen SY; Ren H; Liu XF; Yu ZH; Li YX
Zhonghua Zhong Liu Za Zhi; 2019 Aug; 41(8):615-623. PubMed ID: 31434454
[No Abstract] [Full Text] [Related]
18. Risk-Adapted Postmastectomy Radiotherapy Decision Based on Prognostic Nomogram for pT1-2N1M0 Breast Cancer: A Multicenter Study.
Li M; Yue J; Wan X; Hua B; Yang Q; Yang P; Zhang Z; Pei Q; Han W; Xu Y; Xia X
Front Oncol; 2020; 10():588859. PubMed ID: 33363018
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant regional nodal irradiation did not improve outcomes in T1-2N1 breast cancer after breast-conserving surgery: A propensity score matching analysis of BIG02/98 and BCIRG005 trials.
Qi WX; Cao L; Xu C; Zhao S; Chen J
Breast; 2020 Feb; 49():165-170. PubMed ID: 31812892
[TBL] [Abstract][Full Text] [Related]
20. Increasing utilization of regional nodal irradiation in elderly node-positive women and declining emphasis on demographic factors.
Molitoris JK; Diwanji T; Snider JW; Bellavance EC; Kesmodel SB; Rosenblatt P; Tkaczuk K; Bentzen SM; Cohen RJ; Nichols EM; Cheston SB; Feigenberg SJ
Breast Cancer Res Treat; 2017 Oct; 165(3):669-676. PubMed ID: 28646345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
